NZ510038A - Composition containing a thiomolybdate compound associated with a carbohydrate for the prevention or treatment of cancer - Google Patents

Composition containing a thiomolybdate compound associated with a carbohydrate for the prevention or treatment of cancer

Info

Publication number
NZ510038A
NZ510038A NZ510038A NZ51003899A NZ510038A NZ 510038 A NZ510038 A NZ 510038A NZ 510038 A NZ510038 A NZ 510038A NZ 51003899 A NZ51003899 A NZ 51003899A NZ 510038 A NZ510038 A NZ 510038A
Authority
NZ
New Zealand
Prior art keywords
copper
agent
accordance
cancer
disease
Prior art date
Application number
NZ510038A
Other languages
English (en)
Inventor
George J Brewer
Sofia D Merajver
Dimitri Coucouvanis
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Michigan filed Critical Univ Michigan
Publication of NZ510038A publication Critical patent/NZ510038A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NZ510038A 1998-09-04 1999-09-03 Composition containing a thiomolybdate compound associated with a carbohydrate for the prevention or treatment of cancer NZ510038A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9910398P 1998-09-04 1998-09-04
US10175998P 1998-09-25 1998-09-25
PCT/US1999/020374 WO2000013712A2 (en) 1998-09-04 1999-09-03 Methods and compositions for the prevention or treatment of cancer

Publications (1)

Publication Number Publication Date
NZ510038A true NZ510038A (en) 2003-10-31

Family

ID=26795562

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ510038A NZ510038A (en) 1998-09-04 1999-09-03 Composition containing a thiomolybdate compound associated with a carbohydrate for the prevention or treatment of cancer

Country Status (14)

Country Link
EP (1) EP1107795B1 (ja)
JP (1) JP2002524426A (ja)
KR (1) KR100702279B1 (ja)
CN (1) CN100548383C (ja)
AT (1) ATE228375T1 (ja)
AU (1) AU773848B2 (ja)
CA (1) CA2341752A1 (ja)
DE (1) DE69904203T2 (ja)
DK (1) DK1107795T3 (ja)
ES (1) ES2188261T3 (ja)
IL (1) IL141550A0 (ja)
NZ (1) NZ510038A (ja)
PT (1) PT1107795E (ja)
WO (1) WO2000013712A2 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703050B1 (en) 1998-09-04 2004-03-09 The Regents Of The University Of Michigan Methods and compositions for the prevention or treatment of cancer
WO2003099223A2 (en) * 2002-05-24 2003-12-04 The Regents Of The University Of Michigan Copper lowering treatment of inflammatory and fibrotic diseases
US20070292533A1 (en) * 2002-05-24 2007-12-20 Regents Of The University Of Michigan Copper lowering treatment of autoimmune diseases
US7189865B2 (en) * 2002-07-23 2007-03-13 Attenuon, Llc Thiomolybdate analogues and uses thereof
JP2005538093A (ja) 2002-07-23 2005-12-15 ザ リージェンツ オブ ザ ユニバーシティー オブ ミシガン 抗血管形成療法のための、テトラポリアンモニウムテトラチオモリブデートおよび関連化合物
AU2004247059A1 (en) * 2003-05-27 2004-12-23 Attenuon L.L.C. Thiotungstate analogues and uses thereof
WO2005083107A2 (en) * 2004-02-24 2005-09-09 Attenuon Llp Inhibition of superoxide dismutase by tetrathiomolybdate: identification of new anti-angiogenic and antitumor agents
EP1993607A4 (en) * 2006-01-10 2012-03-28 Pipex Inc PHARMACEUTICAL COMPOSITIONS AND METHODS FOR OBTAINING AND MAINTAINING A TARGETABLE, STABLE COPPER RATE AND PREVENTING AND TREATING CENTRAL NERVOUS SYSTEM DISEASES RELATED TO SERIAL COPPER RATE
WO2009009622A2 (en) * 2007-07-09 2009-01-15 Pipex Pharmaceuticals, Inc. Pharmaceutical compositions, including attm, and methods to achieve and maintain a targeted and stable copper status and prevent and treat copper-related central nervous system diseases
KR100972355B1 (ko) * 2008-05-08 2010-07-26 고려전자주식회사 순간식 가스보일러의 온수공급라인용 써모밸브조립체
US10478455B2 (en) 2010-03-30 2019-11-19 Ucl Business Ltd Therapeutic use of tetrathiomolybdate
GB201005394D0 (en) * 2010-03-30 2010-05-12 Magnus Intellectual Property Ltd Therapy
US20160220500A1 (en) * 2014-11-14 2016-08-04 Kent State University Targeting Intracellular Copper Ions for Inhibiting Angiogenesis Using Nanoparticles of Ternary Inorganic Metal Sulfide M1M2S4 (M1, independently, is Mg, Ca, Mn, Fe, or Zn; M2 = Mo or W) Compounds to Treat Metastatic Cancer
CN108634322A (zh) * 2018-05-16 2018-10-12 刘华 一种预防和调理癌症的方法

Also Published As

Publication number Publication date
CN100548383C (zh) 2009-10-14
ATE228375T1 (de) 2002-12-15
WO2000013712A3 (en) 2000-09-28
AU6496099A (en) 2000-03-27
DK1107795T3 (da) 2003-03-24
EP1107795B1 (en) 2002-11-27
WO2000013712A2 (en) 2000-03-16
DE69904203D1 (de) 2003-01-09
PT1107795E (pt) 2003-04-30
ES2188261T3 (es) 2003-06-16
AU773848B2 (en) 2004-06-10
KR20010082190A (ko) 2001-08-29
EP1107795A2 (en) 2001-06-20
CA2341752A1 (en) 2000-03-16
JP2002524426A (ja) 2002-08-06
CN1457261A (zh) 2003-11-19
IL141550A0 (en) 2002-03-10
KR100702279B1 (ko) 2007-04-02
DE69904203T2 (de) 2003-08-14

Similar Documents

Publication Publication Date Title
US6703050B1 (en) Methods and compositions for the prevention or treatment of cancer
US7888389B2 (en) Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
AU773848B2 (en) Methods and compositions for the prevention or treatment of cancer
UA45964C2 (uk) 2,4-ДИСУЛЬФОНІЛ-<font face="Symbol">a</font>-ФЕНІЛ-ТРЕТ-БУТИЛНІТРОН (ВАРІАНТИ), ЙОГО СОЛІ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), СПОСІБ ЛІКУВАННЯ ПАЦІЄНТА (ВАРІАНТИ)
CA2490541A1 (en) Copper lowering treatment of inflammatory and fibrotic diseases
US6063814A (en) Phorbol esters as anti-neoplastic and white blood cell elevating agents
KR19990036138A (ko) 암 성장을 억제하기 위한 플루코나졸의 용도
AU2021244763A1 (en) Cyclophilin inhibitors and uses thereof
EP1234585A2 (en) Methods and compositions for the prevention or treatment of cancer
BRPI0708645A2 (pt) composições e métodos para o tratamento de artrite reumatóide
TWI772992B (zh) 作為bcl-2抑制劑的n-(苯基磺醯基)苯甲醯胺及相關化合物
JP2018501291A (ja) スルホンアミド系医薬組成物
ZA200101334B (en) Methods and compositions for the prevention or treatment of cancer.
US20080213396A1 (en) Copper Lowering Treatment Of Cardiac Disease
US20240010602A1 (en) Phenyl unsaturated ketones as human factor xiiia inhibitors for treatment of thromboembolic diseases
Toffelmire et al. Plasma exchange in thrombotic thrombocytopenic purpura.
WO2024084086A1 (en) Compositions comprising a benzene sulfonamide thiazole compound
JP2022551373A (ja) 三環式誘導体を用いた脳卒中の治療方法
WO2021022258A1 (en) Tetracycline compounds for the treatment of hematological cancers
Smith " Will my pet be sick?" Understanding chemotherapy toxicities: Parts 1 & 2.
JPH0256327B2 (ja)
JP2007008834A (ja) 糖尿病合併症治療薬
JPS5896019A (ja) 鎌型赤血球貧血症治療剤

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
LAPS Patent lapsed